Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL).

Br J Haematol 2003 Apr;121(1):97-100

Medical Oncology/Haematology, Department of Clinical Research, Inselspital and University of Berne, CH-3010 Berne, Switzerland.

One fifth of B-cell chronic lymphocytic leukaemia (B-CLL) patients exhibit loss of heterozygosity (LOH) at 10q23.3, the site of the tumour suppressor PTEN. Microsatellite markers mapped complete LOH to 10q23.3 in 2/41 B-CLL (5%) and allelic imbalances in 6/41 (15%). No PTEN gene mutations were found. PTEN protein expression was not detected in 11 B-CLL (28%), and was reduced in eight patients (20%). LOH or allelic imbalances at 10q23.3 were fairly frequent in B-CLL, but did not encompass the PTEN gene. Nevertheless, PTEN protein may be absent in B-CLL with a normal PTEN genotype, suggesting a role of this phosphatase in the molecular pathology of B-CLL.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04227.xDOI Listing
April 2003
51 Reads

Publication Analysis

Top Keywords

pten gene
12
lymphocytic leukaemia
8
chronic lymphocytic
8
pten protein
8
leukaemia b-cll
8
loh 10q233
8
allelic imbalances
8
b-cell chronic
8
b-cll
7
pten
7
mapped complete
4
10q233 fairly
4
complete loh
4
10q233 2/41
4
imbalances 10q233
4
markers mapped
4
fairly frequent
4
b-cll encompass
4
suppressor pten
4
pten microsatellite
4

Similar Publications